Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1772081 | 1.00 | KDM4E (0.34) | KDM4ETSHRTDP1CYP1A2CYP2C9 | |
| SCHEMBL1773644 | 1.00 | KDM4E (0.34) | KDM4ETSHRTDP1CYP1A2CYP2C9 | |
| SCHEMBL1772592 | 1.00 | KDM4E (0.34) | KDM4ETSHRTDP1CYP1A2CYP2C9 | |
| SCHEMBL525839 | 0.97 | KDM4E (0.36) | KDM4ETSHRTDP1 | |
| SCHEMBL525110 | 0.88 | KDM4E (0.37) | KDM4ETSHRTDP1 | |
| Iodide SCHEMBL7635296 | 0.85 | KDM4E (0.36) | KDM4ETSHRTDP1 | |
| SCHEMBL5487202 | 0.84 | TSHR (0.42) | KDM4ETSHRTDP1CYP1A2CYP2C9 | |
| SCHEMBL1824897 | 0.84 | TSHR (0.42) | KDM4ETSHRTDP1CYP1A2CYP2C9 | |
| SCHEMBL1827978 | 0.84 | TSHR (0.42) | KDM4ETSHRTDP1CYP1A2CYP2C9 | |
| SCHEMBL5489726 | 0.84 | TSHR (0.42) | KDM4ETSHRTDP1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0077114-B1 | PERFLUOROCHEMICALS, PROCESS FOR PREPARING THE SAME AND THEIR USE AS BLOOD SUBSTITUTES | GREEN CROSS CORPORATION (JP) | 1987-12-02 | — | — | EP | claimed |
| WO-2025057732-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER | ＡＧＣ株式会社 | 2025-03-20 | — | — | WO | disclosed |
| WO-2025057733-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER | ＡＧＣ株式会社 | 2025-03-20 | — | — | WO | disclosed |
| WO-2023111919-A1 | OPTO-ELECTRONIC DEVICE COMPRISING A PATTERNING COATING COMPRISING A PLURALITY OF MATERIALS | OTI LUMIONICS INC. (CA) | 2023-06-22 | — | — | WO | disclosed |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230135489-A1 | FLUORINE-CONTAINING COPOLYMER, COMPOSITION, OPTICAL FILM, LIQUID CRYSTAL FILM, HARDCOAT FILM, AND POLARIZING PLATE | FUJIFILM CORPORATION (JP) | 2023-05-04 | — | — | US | disclosed |
| WO-2023282511-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2023-01-12 | — | — | WO | disclosed |
| EP-3643728-B1 | METHODS FOR PRODUCING FLUORINATED POLYMER, FLUORINATED POLYMER HAVING FUNCTIONAL GROUP AND ELECTROLYTE MEMBRANE | AGC INC (JP) | 2022-08-17 | — | — | EP | disclosed |
| CN-110785443-B | Fluorine-containing polymer, fluorine-containing polymer having functional group, and method for producing electrolyte membrane | ＡＧＣ株式会社 | 2022-06-07 | — | — | CN | disclosed |
| EP-3320540-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | Covestro Deutschland AG (DE) | 2018-05-16 | — | — | EP | disclosed |
| US-20120244478-A1 | RESIST PATTERN FORMATION METHOD | JSR CORPORATION (JP) | 2012-09-27 | — | — | US | disclosed |
| US-8211624-B2 | Method for pattern formation and resin composition for use in the method | JSR CORPORATION (JP) | 2012-07-03 | — | — | US | disclosed |
| US-20120156621-A1 | RADIATION-SENSITIVE RESIN COMPOSITION | JSR CORPORATION (JP) | 2012-06-21 | — | — | US | disclosed |
| EP-2378362-A1 | RESIST PATTERN COATING AGENT AND RESIST PATTERN FORMING METHOD USING THE SAME | JSR Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-20110223544-A1 | RESIST PATTERN COATING AGENT AND RESIST PATTERN FORMING METHOD USING THE SAME | JSR CORPORATION (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110123936-A1 | RESIST PATTERN COATING AGENT AND RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| US-20110111349-A1 | RESIN COMPOSITION FOR MAKING RESIST PATTERN INSOLUBLE, AND METHOD FOR FORMATION OF RESIST PATTERN BY USING THE SAME | JSR CORPORATION (JP) | 2011-05-12 | — | — | US | disclosed |
| US-20100323292-A1 | RESIST PATTERN FORMATION METHOD, AND RESIN COMPOSITION CAPABLE OF INSOLUBILIZING RESIST PATTERN | JSR CORPORATION (JP) | 2010-12-23 | — | — | US | disclosed |
| US-20100190104-A1 | METHOD FOR PATTERN FORMATION AND RESIN COMPOSITION FOR USE IN THE METHOD | JSR CORPORATION (JP) | 2010-07-29 | — | — | US | disclosed |
| EP-2128706-A1 | RESIST PATTERN FORMATION METHOD, AND RESIN COMPOSITION CAPABLE OF INSOLUBILIZING RESIST PATTERN | JSR Corporation (JP) | 2009-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | KDM4E 516/4885TSHR 3804/4885TDP1 3083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.